Showing 901 - 920 results of 1,447 for search '"liver diseases"', query time: 0.11s Refine Results
  1. 901
  2. 902
  3. 903

    Hepatocellular Carcinoma in a 24-Year-Old Female with Beckwith–Wiedemann Syndrome: A Case Report and Review of the Literature by Carolyn G. Ahlers, Quoc-Huy Trinh, Martin Montenovo

    Published 2020-01-01
    “…Although HCC typically occurs in elderly adults or those with underlying liver disease, in this case, we show that HCC can occur in a young adult with BWS without any underlying liver disease.…”
    Get full text
    Article
  4. 904

    Role of NKT Cells in the Pathogenesis of NAFLD by Kazuto Tajiri, Yukihiro Shimizu

    Published 2012-01-01
    “…Nonalcoholic fatty liver disease (NAFLD) is the most frequent chronic liver disease and shows various inflammatory changes in the liver. …”
    Get full text
    Article
  5. 905

    Recent advances in polymeric nanoparticles for the treatment of hepatic diseases by Feng Gao, Xuefei Feng, Xinyu Li

    Published 2025-01-01
    “…Compared to traditional therapies, they offer significant advantages in the treatment of liver disease by improving outcomes and reducing side effects. …”
    Get full text
    Article
  6. 906

    Case of acute drug-induced hepatitis after halothane anesthesia by I. Yu. Pirogova, Ye. V. Berestova, O. Yu. Bastrikov, Ye. B. Kovaleva, T. P. Petukhova, M. V. Guseva, I. A. Gubina, I. V. Rezepin, S. P. Sinitsyn

    Published 2013-05-01
    “…The most important factors determining favorable prognosis at drug-induced liver disease, include adequate doses of glucocorticosteroids, application of MARS-therapy and absence of background liver disease. …”
    Get full text
    Article
  7. 907

    Investigation of the healing effects of Afyon Province hot spring waters on experimentally-induced fatty liver in mice by Bülent Elitok, Ibrahim Kişlalioğlu, Yavuz Ulusoy, Bahadır Kilinç

    Published 2020-09-01
    “…Due the increasing number of alcoholic fatty liver disease cases in the world, the development of methods for treating this disease is an urgent task. …”
    Get full text
    Article
  8. 908

    Multi-omics reveals the mechanism of Trimethylamine N-oxide derived from gut microbiota inducing liver fatty of dairy cows by Chenlei Li, Feifei Wang, Yongxia Mao, Yanfen Ma, Yansheng Guo

    Published 2025-01-01
    “…However, the specific role and pathogenesis of TMAO in bovine fatty liver disease remain unclear, limiting our understanding and treatment of the condition. …”
    Get full text
    Article
  9. 909

    Impact of underlying diseases and complications on COVID-19 mortality in South Korea: analysis of national health insurance service data by Kyunghee Lee, Jieun Hwang

    Published 2025-01-01
    “…Except for liver disease, all underlying diseases were associated with mortality. …”
    Get full text
    Article
  10. 910

    Serum Endocan as a Survival Predictor for Patients with Liver Cirrhosis by Nobuyuki Toshikuni, Kazuaki Ozaki, Joseph George, Mikihiro Tsutsumi

    Published 2015-01-01
    “…BACKGROUND: The relationship between endocan expression and outcome in patients with chronic liver disease is not fully understood.…”
    Get full text
    Article
  11. 911

    Drug Advances in NAFLD: Individual and Combination Treatment Strategies of Natural Products and Small-Synthetic-Molecule Drugs by Xing Wan, Jingyuan Ma, He Bai, Xuyang Hu, Yanna Ma, Mingjian Zhao, Jifeng Liu, Zhijun Duan

    Published 2025-01-01
    “…Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease and is closely associated with metabolic diseases such as obesity, type 2 diabetes mellitus (T2DM), and metabolic syndrome. …”
    Get full text
    Article
  12. 912

    Penyeimbangan Kelas SMOTE dan Seleksi Fitur Ensemble Filter pada Support Vector Machine untuk Klasifikasi Penyakit Liver by Muhammad Amir Nugraha, Muhammad Itqan Mazdadi, Andi Farmadi, Muliadi, Triando Hamonangan Saragih

    Published 2023-12-01
    “…Classification of liver disease in patients needs to be done well because the results can help in the initial diagnosis of whether a patient has liver disease. …”
    Get full text
    Article
  13. 913

    Wilson’s Disease and Autoimmune Hepatitis Coexistence: A Cause of Diagnostic Delay by Mohammed G Mudawi, Salma Barakat MD, Elhadi M Awooda

    Published 2023-09-01
    “…Wilson’s disease, although rare, should be suspected in patients with decompensated liver disease. The dominance of clinical and epidemiological features of autoimmune hepatitis as a common causative pathology for chronic liver disease in young and middle-aged ladies may hide the presence of other serious different pathologies such as Wilson’s disease. …”
    Get full text
    Article
  14. 914

    The Interstitial Lymphatic Peritoneal Mesothelium Axis in Portal Hypertensive Ascites: When in Danger, Go Back to the Sea by M. A. Aller, I. Prieto, S. Argudo, F. de Vicente, L. Santamaría, M. P. de Miguel, J. L. Arias, J. Arias

    Published 2010-01-01
    “…But, the adult human being would take advantage of the potential beneficial effects of this “amniotic-like fluid” to manage the interstitial fluids without adverse effects when chronic liver disease aggravates.…”
    Get full text
    Article
  15. 915

    Efficacy and Safety of a Novel Pegylated Interferon Alpha-2a in Egyptian Patients with Genotype 4 Chronic Hepatitis C by Alaa Awad Taha, Ahmad El-Ray, Maged El-Ghannam, Bahaa Mounir

    Published 2010-01-01
    “…BACKGROUND: Hepatitis C virus (HCV) genotype 4 is a common infection in Egypt and is the leading cause of liver disease.…”
    Get full text
    Article
  16. 916

    The Feasibility and Reliability of Transient Elastography Using Fibroscan®: A Practice Audit of 2335 Examinations by Jack XQ Pang, Faruq Pradhan, Scott Zimmer, Sophia Niu, Pam Crotty, Jenna Tracey, Christopher Schneider, Steven J Heitman, Gilaad G Kaplan, Mark G Swain, Robert P Myers

    Published 2014-01-01
    “…BACKGROUND: Liver stiffness measurement (LSM) using transient elastography is widely used in the management of patients with chronic liver disease.…”
    Get full text
    Article
  17. 917

    Gambaran Profil Lipid Pasien Perlemakan Hati Non-Alkoholik by Vanny Syafitri, Arnelis ., Efrida .

    Published 2015-01-01
    “…<p>Abstrak<br />Penyakit perlemakan hati non-alkoholik (non-alcoholic fatty liver disease) merupakan kondisi klinis yang sering ditemukan dalam bidang hepatologi. …”
    Get full text
    Article
  18. 918

    Probiotics for Alleviating Alcoholic Liver Injury by Zelin Gu, Yanlong Liu, Shumeng Hu, Ying You, Jiaqi Wen, Wancong Li, Yuhua Wang

    Published 2019-01-01
    “…In this review, we summarize the current knowledge regarding the mechanism of action of probiotics for reducing the effects of alcoholic liver disease.…”
    Get full text
    Article
  19. 919

    The Use of Antibiotics for the Prophylaxis of Spontaneous Bacterial Peritonitis: A Retrospective Review and Quality Improvement Study by Ariana Tagliaferri, Nida Ansari, Gabriel Melki, Yana Cavanagh

    Published 2024-01-01
    “…Conclusion: We intend to educate providers on the appropriate time to intervene to reduce mortality and subsequent hospitalizations for those with advanced liver disease.…”
    Get full text
    Article
  20. 920

    Multiple Bone Metastases as the First Manifestation of Hepatocellular Carcinoma in Patient with Noncirrhotic Liver by Soo Ya Bae, Hyun Jung Kim, Hyun Ho Oh, Min Kwan Kwon, Jong Ho Lee, Moon Park, Byeong Seok Sohn

    Published 2015-01-01
    “…Hepatocellular carcinoma (HCC) generally occurs on the background of chronic liver disease. Chronic hepatitides B and C and alcoholic liver disease are well-known risk factors for HCC, and it is uncommon in noncirrhotic liver. …”
    Get full text
    Article